In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to HFA Silver & Gold Members, Fellows of the ESC and Young combined Members

Neutrophil to lymphocyte ratio as a predictor of myocardial injury in patients presenting with myocarditis

Session Poster Session 3

Speaker Borges Sara

Congress : Heart Failure 2019

  • Topic : valvular, myocardial, pericardial, pulmonary, congenital heart disease
  • Sub-topic : Myocarditis
  • Session type : Poster Session
  • FP Number : P1809

Authors : S Borges (Vila Real,PT), F Goncalves (Vila Real,PT), JP Guimaraes (Vila Real,PT), JJ Monteiro (Vila Real,PT), C Ferreira (Vila Real,PT), JI Moreira (Vila Real,PT)

S Borges1 , F Goncalves1 , JP Guimaraes1 , JJ Monteiro1 , C Ferreira1 , JI Moreira1 , 1Hospital Center of Tras-os-Montes and Alto Douro, Cardiology - Vila Real - Portugal ,


Background: There is a growing body of evidence highlighting the role of neutrophil to lymphocyte ratio (NLR) as prognostic predictor in several cardiovascular diseases, as a marker of systemic inflammation. Therefore, our aim is to describe the association of NLR and myocardial injury and function in patients with myocarditis;

Methods: Data from patients discharged with the diagnosis of myocarditis, from January of 2008 and October of 2018, in one center, were retrospectively analysed. NLR was defined as the ration of absolute counts of neutrophils and lymphocytes, at admission;

Results: 63 patients were included. Mean age was 39.7  17 years and 89% (58 patients) were men. The NLR values ranged from 1.1 to 14.78 (median 3.48, interquartile range (IQR) 3.06), without significant differences between women and men. In this population, NLR positively correlates with peak troponin values (p= 0.004, r=0.35) and N-terminal pro B-type natriuretic peptide (NT- proBNP) values (p= 0.005, R= 0.35). NLR also positively correlates with other inflammatory makers, such as C-reactive protein (CRP) (p<0.001, r= 0.42), leukocytes (p<0.001, r=0.59) and monocytes (p=0.004, r=0.35). NLR was higher in patients with left ventricular systolic dysfunction (4.45 vs 3.43) but this difference was not statistically significant (p=0.341);

When the patients were divided into NLR>3.48 and NLR<3.48 groups, myocardial injury markers were significantly increased in the higher NLR group (peak troponin 1.53 vs 0.6, p <0.001 and NT- proBNP 654 vs 244, p= 0.044). There is a statistically significant association between higher NLR and need of inotropic support (p=0.024). No differences on in-hospital mortality (p=0.492) between groups were registered.

Conclusion: NLR is a predictor of myocardial injury and inflammation in this group of patients; Despite being nonspecific, it is a readily available marker and it could be a cost-effective predictor and a useful tool to guide the approach  in these patients.

Based on your interests

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are